Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

First Major Trial Win for Contemporary DOACs in Lower-Risk Afib

(MedPage Today) -- Emerging randomized data favored oral anticoagulation for lower-risk patients with atrial fibrillation (Afib), researchers found. Among patients with Afib and one thromboembolic risk factor in the SINGLE-AF trial, direct oral...

First Major Trial Win for Contemporary DOACs in Lower-Risk Afib

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 28 August →